Latest Content

A recent survey reveals that 13% of US youth use generative AI for mental health advice, highlighting its perceived benefits and potential risks.

New neuroimaging data reveals XPro1595's potential to combat neuroinflammation in early Alzheimer’s disease, offering hope for slowing progression.

Explore the complexities of mental illness, its definitions, and the limitations of current psychiatric diagnosis in understanding true psychopathology.

Bristol Myers Squibb expands patient enrollment in the ADEPT-2 study, exploring Cobenfy's potential for treating Alzheimer disease-related psychosis.

Explore impactful ways to contribute on Giving Tuesday, supporting mental health organizations dedicated to making a difference in psychiatry.

Meta-analysis identifies 2 antidepressants that separate from placebo and other antidepressants in relieving negative symptoms of schizophrenia

Adolescent cannabis use surges in Oklahoma, raising public health concerns amid rising THC potency and permissive regulations.

Discover the positive shifts in psychiatry, from youth mental health improvements to innovative treatment technologies, amidst current challenges.

What are the most important psychiatric advancements and insights from 2025? Share with us!

ChatGPT's rapid rise sparks debate on its profound impact, blending remarkable capabilities with alarming risks, as society grapples with AI's future.

Explore the importance of gratitude in psychiatry, addressing challenges, stigma, and the pursuit of mental health improvement in communities.

Explore updates from November 2025, including AI, drug updates, and more.

Check out the pipeline updates from November!